Stryker Corp
NYSE:SYK

Watchlist Manager
Stryker Corp Logo
Stryker Corp
NYSE:SYK
Watchlist
Price: 389.71 USD 1.25% Market Closed
Market Cap: 148.6B USD
Have any thoughts about
Stryker Corp?
Write Note

Stryker Corp
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stryker Corp
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
14%
CAGR 10-Years
19%
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
Edwards Lifesciences Corp
NYSE:EW
Income from Continuing Operations
$1.4B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
6%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
14%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.3B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
18%
No Stocks Found

Stryker Corp
Glance View

Market Cap
148.6B USD
Industry
Health Care

Stryker Corporation, a prominent player in the global medical technology landscape, has carved out a reputation for innovation and reliability since its founding in 1941. Specializing in developing and manufacturing a diverse range of products, Stryker's offerings span surgical equipment, implantable devices, and medical instruments, all designed to enhance patient care and improve clinical outcomes. Fueled by a commitment to quality and continuous improvement, the company invests heavily in research and development, leading the way with cutting-edge technologies like robotic surgical systems and advanced orthopedic solutions. The company’s strong market position is bolstered by its strategic acquisitions, which not only expand its product portfolio but also deepen its penetration into key medical segments, allowing Stryker to sustain impressive growth rates. For investors, Stryker represents a compelling opportunity in the healthcare sector, driven by the increasing demand for advanced medical solutions in an aging global population. With a presence in over 100 countries, Stryker's diversified revenue streams reduce risk and enhance resilience against market fluctuations. The company consistently delivers solid financial performance, characterized by robust margins and healthy cash flows, which it strategically reinvests to fuel future growth. Furthermore, its strong commitment to sustainability and corporate responsibility positions Stryker favorably in a market increasingly concerned with ethical practices. As the healthcare industry continues to evolve, Stryker’s innovative edge and solid fundamentals make it a captivating prospect for investors seeking long-term stability and growth.

SYK Intrinsic Value
290.55 USD
Overvaluation 25%
Intrinsic Value
Price

See Also

What is Stryker Corp's Income from Continuing Operations?
Income from Continuing Operations
3.6B USD

Based on the financial report for Sep 30, 2024, Stryker Corp's Income from Continuing Operations amounts to 3.6B USD.

What is Stryker Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
19%

Over the last year, the Income from Continuing Operations growth was 39%. The average annual Income from Continuing Operations growth rates for Stryker Corp have been 24% over the past three years , 14% over the past five years , and 19% over the past ten years .

Back to Top